Major Drug Classes and Their Chemistry
CSIR NET medicinal chemistry: beta-lactams, sulfonamides, antivirals, anticancer agents, NSAIDs, cardiovascular and CNS drugs, and their SAR.
- 14 min
On this page · 16 sections
- Prerequisites
- The Hook: Four Membered Rings and a Century of Chemistry
- Antibacterial Agents
- Antiviral and Antifungal Agents
- Anticancer Agents
- Anti-inflammatory and Analgesic Agents
- Cardiovascular and Gastrointestinal Agents
- Central Nervous System Agents
- Heterocycles: Why They Are Everywhere
- Memory Tricks
- Don’t Confuse
- Common Mistakes
- Practice
- Quick Revision Table
- Key Takeaways
- What’s Next
Prerequisites
- Target types, inhibition and receptor language used throughout: Drug Targets and Molecular Basis of Drug Action.
- Prodrug activation and metabolic stability of these classes: Drug Metabolism, Prodrugs and Pharmacokinetics.
- Heterocyclic cores that appear in almost every class: Pyrrole, Furan and Thiophene and Pyridine, Pyridones and Pyrylium Salts.
- Natural-product scaffolds that gave many of these leads: Carbohydrates and Amino Acids, Peptides and Proteins.
- Platinum and other metallodrugs, treated separately: Metal Complexes in Medicine.
The Hook: Four Membered Rings and a Century of Chemistry
Antibacterial Agents
Cell-wall synthesis: β-lactams
The bicyclic penicillin core is 6-aminopenicillanic acid (β-lactam fused to a thiazolidine); cephalosporins have the β-lactam fused to a six-membered dihydrothiazine ring (7-aminocephalosporanic acid). Both acylate the active-site serine of the transpeptidase (penicillin-binding protein) that cross-links peptidoglycan.
| SAR point | Consequence |
|---|---|
| Ring strain + poor amide resonance | the carbonyl is electrophilic enough to acylate serine |
| Free carboxylate | required for binding; esterified penicillins are prodrugs |
| 6-Acylamino side chain | varied to tune spectrum, acid stability and β-lactamase resistance |
| Electron-withdrawing side chain (phenoxymethyl) | survives stomach acid — oral penicillin V |
| Bulky ortho-substituted aryl side chain | sterically blocks β-lactamase (the methicillin-type design) |
| Polar group (NH\(_2\), COOH) on the side chain | broader Gram-negative spectrum (aminopenicillins, carboxypenicillins) |
Resistance comes mainly from β-lactamases, which hydrolyse the ring. The chemical answer is a second molecule: clavulanic acid, sulbactam and tazobactam are β-lactamase inhibitors, clavulanate acting as a mechanism-based inactivator, given in combination with a penicillin. Other resistance routes are altered penicillin-binding proteins and efflux.
Other cell-wall agents: glycopeptides such as vancomycin, which bind the D-Ala-D-Ala substrate itself rather than the enzyme (resistance arises when the terminus changes to D-Ala-D-lactate), and cycloserine and fosfomycin, which block earlier steps.
Protein synthesis: the ribosome
| Class | Subunit | Chemistry |
|---|---|---|
| Aminoglycosides (streptomycin, gentamicin) | 30S | highly polar aminosugars; poor oral absorption |
| Tetracyclines | 30S | linear tetracyclic, chelates divalent metals (hence interaction with Ca\(^{2+}\)/Mg\(^{2+}\)) |
| Macrolides (erythromycin type) | 50S | large lactone ring glycosylated with amino- and deoxysugars; acid-labile ketalisation is designed out in later analogues |
| Chloramphenicol | 50S | nitroaromatic dichloroacetamide; peptidyl transferase inhibitor |
| Oxazolidinones | 50S | block initiation-complex formation |
Nucleic acid and folate pathways
- Quinolones/fluoroquinolones: 4-quinolone-3-carboxylic acids inhibiting DNA gyrase and topoisomerase IV. The C-6 fluorine and C-7 amine (commonly a piperazine) are classic potency- and spectrum-determining substituents; the 3-carboxylate and 4-oxo pair is essential and also chelates metal ions.
- Sulfonamides: structural analogues of p-aminobenzoic acid that competitively inhibit dihydropteroate synthase. The free aromatic NH\(_2\) para to the sulfonamide is required, and N\(^1\)-substitution tunes acidity and solubility. They are antimetabolites: humans do not make folate, so the pathway is absent in us.
- Trimethoprim: a 2,4-diaminopyrimidine inhibiting bacterial dihydrofolate reductase far more tightly than the human enzyme. Combined with a sulfonamide it blocks the same pathway at two points.
- Rifamycins: inhibit bacterial DNA-dependent RNA polymerase; note their strong enzyme-inducing effect in the host.
graph TD
A["Folate pathway"] --> B["PABA + pteridine
dihydropteroate synthase"]
B -->|"blocked by sulfonamides"| C["Dihydrofolate"]
C --> D["Dihydrofolate reductase"]
D -->|"blocked by trimethoprim (bacterial)
methotrexate (human, anticancer)"| E["Tetrahydrofolate"]
E --> F["Thymidylate synthase
(blocked by 5-FU as FdUMP)"]
F --> G["dTMP, DNA synthesis"]Antiviral and Antifungal Agents
| Class | Target | Key chemistry |
|---|---|---|
| Nucleoside analogues (acyclovir, zidovudine) | viral polymerase / reverse transcriptase | lack a free 3′-OH, so incorporation terminates the chain; acyclovir needs viral thymidine kinase for the first phosphorylation |
| Non-nucleoside reverse transcriptase inhibitors | allosteric pocket of RT | non-competitive; resistance arises from single pocket mutations |
| Protease inhibitors | viral aspartyl protease | peptidomimetics with a non-hydrolysable transition-state isostere (hydroxyethylene, hydroxyethylamine) |
| Neuraminidase inhibitors | viral neuraminidase | transition-state mimics of the sialic acid oxocarbenium ion; one widely used member is an ester prodrug |
| Azole antifungals | fungal lanosterol 14α-demethylase (a P450) | the imidazole or triazole nitrogen coordinates the haem iron; selectivity over human P450s is never perfect, hence interactions |
| Polyenes (amphotericin B) | ergosterol in the fungal membrane | large polyene macrolactone; binds sterol and permeabilises the membrane |
The azoles are the clearest case of inorganic chemistry inside a drug: a basic sp\(^2\) nitrogen of the heterocycle is the iron-binding group, and the rest of the molecule is the specificity handle.
Anticancer Agents
| Class | Mechanism |
|---|---|
| Alkylating agents (nitrogen mustards, nitrosoureas, busulfan) | generate an aziridinium or similar electrophile; bifunctional agents cross-link DNA at N7 of guanine |
| Platinum complexes | 1,2-intrastrand cross-links; see Metal Complexes in Medicine |
| Antimetabolites | methotrexate (DHFR), 5-fluorouracil (thymidylate synthase via FdUMP), purine and pyrimidine analogues |
| Topoisomerase poisons / intercalators | anthracyclines, camptothecin-type and podophyllotoxin-derived agents |
| Antimitotics | vinca alkaloids and colchicine-site agents prevent tubulin polymerisation; taxanes stabilise microtubules |
| Targeted agents | kinase inhibitors occupying the ATP site, usually built on a heteroaromatic hinge-binding motif |
Cyclophosphamide is worth remembering as a prodrug: it is oxidised in the liver and the activated species decomposes to the DNA-alkylating mustard plus acrolein. The design point is that the administered molecule is not itself an alkylating agent.
Anti-inflammatory and Analgesic Agents
| Class | Target | Chemistry |
|---|---|---|
| Aspirin | cyclo-oxygenase | irreversible: the acetyl group is transferred to an active-site serine |
| Other NSAIDs (arylalkanoic acids, arylpropionic acids, fenamates) | cyclo-oxygenase | reversible, competitive; an acidic group plus a lipophilic aromatic system is the common pharmacophore |
| COX-2-selective agents (“coxibs”) | COX-2 isoform | bulky sulfone or sulfonamide group exploits a larger side pocket in COX-2 |
| Paracetamol | distinct from classical NSAID action | metabolically interesting (see NAPQI) |
| Opioid analgesics | opioid receptors | morphinan skeleton; free phenolic OH and basic nitrogen are key — 3-O-methylation gives codeine, a prodrug; N-allyl or N-cyclopropylmethyl substitution converts agonist to antagonist (naloxone, naltrexone) |
| Steroidal anti-inflammatories | nuclear glucocorticoid receptor | steroid nucleus with 11-OH and 3-keto-Δ4; fluorination at C-9 raises potency |
The opioid SAR is one of the most quotable in the subject: the same skeleton gives an agonist or an antagonist depending only on the nitrogen substituent.
Cardiovascular and Gastrointestinal Agents
| Class | Target / mechanism | Chemistry worth knowing |
|---|---|---|
| β-Blockers | β-adrenoceptors | aryloxypropanolamine chain; the \( S \) enantiomer carries most of the activity; aryl group governs β\(_1\) selectivity |
| ACE inhibitors | angiotensin-converting enzyme (a zinc peptidase) | designed around a zinc-binding group: thiol (captopril) or carboxylate (enalaprilat, given as the ester prodrug enalapril) |
| Dihydropyridine Ca\(^{2+}\)-channel blockers | L-type calcium channel | 1,4-dihydropyridine from a Hantzsch-type synthesis; a 4-aryl group is essential |
| Statins | HMG-CoA reductase | dihydroxy-acid (or lactone prodrug) mimicking the reaction intermediate |
| Nitrates | nitric-oxide donors | organic nitrate esters releasing NO, a vasodilator signalling molecule |
| H\(_2\) antagonists | histamine H\(_2\) receptor | the classic rational-design story: an imidazole-containing lead with a polar, non-basic side chain, later analogues replacing the imidazole by furan or thiazole |
| Proton-pump inhibitors | gastric H\(^+\)/K\(^+\)-ATPase | acid-activated prodrug: the benzimidazole sulfoxide cyclises to a sulfenamide that forms a disulfide with an enzyme cysteine |
Central Nervous System Agents
| Class | Mechanism in one line |
|---|---|
| Benzodiazepines | positive allosteric modulators at the GABA\(_A\) receptor |
| Barbiturates | act at the same receptor complex, with a different and less forgiving margin |
| Tricyclic and SSRI antidepressants | block monoamine (serotonin/noradrenaline) reuptake transporters |
| Monoamine oxidase inhibitors | block oxidative deamination of monoamines |
| Typical/atypical antipsychotics | dopamine D\(_2\) (and, for the atypicals, additional serotonin receptor) antagonism |
| Levodopa | prodrug of dopamine, carried across the blood–brain barrier by an amino-acid transporter |
| Local anaesthetics | block voltage-gated Na\(^+\) channels; ester-linked members are hydrolysed quickly, amide-linked ones last longer |
CNS activity imposes its own physicochemical rules: lower molecular mass, fewer hydrogen-bond donors and a smaller polar surface area than a typical oral drug, because the blood–brain barrier is far less permissive than the gut wall.
Heterocycles: Why They Are Everywhere
| Ring | Why medicinal chemists use it |
|---|---|
| Pyridine | basic but not protonated at pH 7.4, lowers \( \log P \), good acceptor |
| Imidazole / triazole | metal binder (azoles at haem iron), acceptor and donor |
| Piperazine, morpholine | solubilising basic groups, easy to attach |
| Indole | privileged scaffold from tryptophan-derived biology |
| Pyrimidine / purine | nucleic-acid mimicry (antimetabolites, kinase hinge binders) |
| Tetrazole | carboxylic-acid bioisostere |
| Thiophene, furan | phenyl replacements with different metabolic liabilities (be alert to oxidation to reactive species) |
Heterocycles let a chemist tune \( pK_a \), solubility, metabolic stability and hydrogen-bonding pattern while keeping shape — the practical face of bioisosterism.
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| Penicillins (thiazolidine-fused) | Cephalosporins (dihydrothiazine-fused) | |
| β-Lactamase inhibitor (clavulanate) | β-Lactam antibiotic (amoxicillin) — the combination needs both | |
| Vancomycin (binds the substrate D-Ala-D-Ala) | Penicillin (acylates the enzyme) | |
| Sulfonamide antibacterial (PABA antimetabolite) | Sulfonylurea or other sulfonamide-containing drugs with unrelated targets | |
| Trimethoprim (bacterial DHFR) | Methotrexate (human DHFR, anticancer) | |
| Aspirin (irreversible COX acetylation) | Other NSAIDs (reversible, competitive) | |
| Vinca alkaloids (block polymerisation) | Taxanes (stabilise microtubules) | |
| Codeine (3-O-methyl prodrug) | Naloxone (N-substituted antagonist) |
Common Mistakes
Practice
All questions below are original practice questions written for this page. They are not from any CSIR NET paper.
Level 1: Foundation
- Which enzyme do sulfonamides inhibit, and which metabolite do they mimic?
- What structural change converts an opioid agonist into an antagonist?
- Name the ribosomal subunit targeted by tetracyclines.
Answers
- Dihydropteroate synthase; they mimic p-aminobenzoic acid (PABA).
- Replacing the N-methyl by N-allyl or N-cyclopropylmethyl (naloxone, naltrexone).
- The 30S subunit.
Level 2: Part B Style
Practice Q1. Vancomycin differs mechanistically from penicillin in that it:
(a) inhibits the 50S subunit (b) binds the D-Ala-D-Ala peptide terminus rather than the transpeptidase (c) is a β-lactamase inhibitor (d) blocks DNA gyrase
Answer: (b)
Vancomycin sequesters the substrate; penicillin acylates the enzyme. This is also why resistance to vancomycin arises by changing the terminus to D-Ala-D-lactate.
Practice Q2. Azole antifungals act by:
(a) binding ergosterol directly (b) coordinating the haem iron of lanosterol 14α-demethylase (c) inhibiting the 30S ribosomal subunit (d) cross-linking fungal DNA
Answer: (b)
A basic ring nitrogen of the imidazole or triazole coordinates the P450 haem iron. Option (a) describes the polyenes such as amphotericin B.
Practice Q3. Which pair acts at two consecutive steps of the same pathway?
(a) Aspirin and paracetamol (b) Sulfamethoxazole and trimethoprim (c) Vincristine and paclitaxel (d) Acyclovir and zidovudine
Answer: (b)
The sulfonamide blocks dihydropteroate synthase and trimethoprim the bacterial dihydrofolate reductase — sequential blockade of folate synthesis.
Practice Q4. The acid stability of penicillin V relative to penicillin G is attributed to:
(a) the free carboxylate (b) an electron-withdrawing phenoxymethyl side chain that disfavours side-chain participation in ring opening (c) the thiazolidine sulfur (d) a larger β-lactam ring
Answer: (b)
An electron-withdrawing group on the side chain reduces neighbouring-group participation by the side-chain amide in acid-catalysed opening of the β-lactam, so the oral route becomes practical. The carboxylate and the thiazolidine are common to both.
Level 3: Part C Style
Practice Q5. A bacterial strain is resistant to amoxicillin but susceptible to amoxicillin + clavulanate. A second strain is resistant to both. Which statements are consistent?
- The first strain most likely produces a β-lactamase that clavulanate inactivates.
- The second strain’s resistance may involve an altered penicillin-binding protein.
- The second strain’s resistance may involve a β-lactamase not inhibited by clavulanate.
- Clavulanate restores activity because it is itself a potent antibacterial.
(a) 1, 2 and 3 only (b) 1 and 4 only (c) 2, 3 and 4 only (d) 1, 2, 3 and 4
Answer: (a) 1, 2 and 3 only
1–3 are the standard resistance routes (enzymatic hydrolysis, target alteration, an enzyme outside the inhibitor’s spectrum; efflux is a fourth). 4 is wrong: clavulanate’s contribution is protection of the partner β-lactam, not intrinsic potency.
Practice Q6. Consider four agents: (i) methotrexate, (ii) 5-fluorouracil, (iii) cyclophosphamide, (iv) paclitaxel. Which statements are correct?
- (i) is a competitive inhibitor of dihydrofolate reductase.
- (ii) must be converted to FdUMP before it inhibits thymidylate synthase.
- (iii) is a prodrug requiring hepatic oxidation before it can alkylate DNA.
- (iv) prevents tubulin polymerisation.
(a) 1, 2 and 3 only (b) 1, 3 and 4 only (c) 2, 3 and 4 only (d) 1, 2, 3 and 4
Answer: (a) 1, 2 and 3 only
- Methotrexate is a folate analogue competing at the DHFR folate site. Correct.
- The nucleotide FdUMP is the species that traps thymidylate synthase. Correct.
- Cyclophosphamide is activated by hepatic oxidation; the mustard is released downstream. Correct.
- Taxanes stabilise microtubules; the vinca alkaloids prevent polymerisation. Wrong.
Practice Q7. A new quinolone analogue is prepared. Which structural statements are consistent with the known SAR of the class?
- Removing the 3-carboxylic acid abolishes activity.
- A fluorine at C-6 generally increases potency.
- A nitrogen heterocycle such as piperazine at C-7 influences spectrum and pharmacokinetics.
- The drug acts by inhibiting bacterial RNA polymerase.
(a) 1, 2 and 3 only (b) 1, 2, 3 and 4 (c) 2 and 4 only (d) 1 and 4 only
Answer: (a) 1, 2 and 3 only
The 3-carboxy/4-oxo pair is essential (it also chelates metal ions, which explains why di- and trivalent cations reduce absorption); C-6 fluorine and a C-7 amine are the classic potency and spectrum handles. The target is DNA gyrase/topoisomerase IV, not RNA polymerase (that is the rifamycins). 4 wrong.
Quick Revision Table
| Class | Target | Remember |
|---|---|---|
| β-Lactams | transpeptidase (PBP) | strained ring acylates serine; clavulanate guards against β-lactamase |
| Glycopeptides | D-Ala-D-Ala substrate | binds substrate, not enzyme |
| Aminoglycosides, tetracyclines | 30S | polar; tetracyclines chelate metals |
| Macrolides, chloramphenicol, oxazolidinones | 50S | large lactone / nitroaromatic / initiation block |
| Quinolones | DNA gyrase, topo IV | 3-COOH + 4-oxo essential; C-6 F, C-7 amine |
| Sulfonamides | dihydropteroate synthase | PABA antimetabolite; free para NH\(_2\) |
| Trimethoprim / methotrexate | bacterial / human DHFR | selectivity by enzyme difference |
| Nucleoside antivirals | viral polymerase, RT | chain termination; acyclovir needs viral TK |
| HIV protease inhibitors | aspartyl protease | transition-state isostere |
| Azoles / polyenes | 14α-demethylase / ergosterol | iron coordination / membrane permeabilisation |
| Alkylators, Pt, antimetabolites, topo poisons, antimitotics | DNA and mitosis | vinca destabilises, taxane stabilises |
| Aspirin / NSAIDs / coxibs | COX | irreversible acetylation vs reversible; COX-2 side pocket |
| Opioids | opioid receptors | N-substituent decides agonist or antagonist |
| β-Blockers, ACE inhibitors, dihydropyridines, statins, PPIs | cardiovascular / GI | zinc-binding group, 1,4-DHP core, acid-activated sulfenamide |
Key Takeaways
What’s Next
- Medicinal Chemistry: Quick Revision: every formula, target and trap on one page.
- Drug Targets and Molecular Basis of Drug Action: revisit the quantitative side with these classes in mind.
- Metal Complexes in Medicine: platinum drugs, imaging agents and chelation therapy.
- Heterocyclic chemistry: Pyridine, Pyridones and Pyrylium Salts: the Hantzsch synthesis behind the dihydropyridines.